| Pharmaceutical active ingredients: |
| Coagulation Factor VIII Human |
| Available forms, composition and doses of Alpha VIII: |
| N / A |
| Alpha VIII medical category: |
| Human:Hemostatics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B02BD02 - Coagulation Factor VIII |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alpha Therapeutic Corporation |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
8Y | Coagulation Factor VIII Human | Galenica, Greece |
| Agemfil A | Coagulation Factor VIII Human | Hematology Research Center RAMN |
| AHF | Coagulation Factor VIII Human | CSL |
| AHG | Coagulation Factor VIII Human | Unidentified Pharmaceutical Company |
| Aleviate | Coagulation Factor VIII Human | CSL; Primal Chemical; United Italian Trading |
| Alphanate | Coagulation Factor VIII Human | Grifols; Alpha Therapeutic Corporation; DKSH; Edward Keller; Four Star; Great Year Trading; Pacific Healthcare |
| Amofil | Coagulation Factor VIII Human | Veripalvelu Suomen Punainen Risti |
| Antihemophillic Factor Human Hemofil M, Method M, Monoclonal Purified | Coagulation Factor VIII Human | Baxter |
| Cryoprecipitate | Coagulation Factor VIII Human | Astrakhan Regional Blood Transfusion Station |
| Cryoprecipitate | Coagulation Factor VIII Human | Belgorod Regional Blood Transfusion Station |